Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol in Septic Shock (ECASSS-R)
NCT02841241Phase 2Completed
- Sponsor
- Intermountain Health
- Start
- Apr 2016
- Primary completion
- Mar 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of esmolol in septic shock, sponsored by Intermountain Health. Started Apr 2016; status: completed.
02
Drugs
esmolol
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02841241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02841241.